Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05165433 |
| Title | Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours (FORTIFY) (FORTIFY) |
| Acronym | FORTIFY |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | PsiOxus Therapeutics Ltd |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Providence Medical Foundation | Santa Monica | California | 90404 | United States | Details | |
| UCLA | Santa Monica | California | 90404 | United States | Details | |
| Moffitt-Advent Health Clinical Research Unit | Celebration | Florida | 34747 | United States | Details | |
| Perelman Center of Advanced Medicine | Philadelphia | Pennsylvania | 19104 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| The Clatterbridge Cancer Centre NHS Foundation Trust | Liverpool | Lancashire | L7 8YA | United Kingdom | Details | |
| Churchill Hospital, Oxford University Hospitals NHS Foundation Trust | Oxford | Oxfordshire | OX3 7LE | United Kingdom | Details |